Stock listing

IPSC Stock Price, News, Filings & Events — Century Therapeutics, Inc.

Selected listing: IPSC · NASDAQ · USD · US

This page tracks Century Therapeutics, Inc.'s IPSC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPSC:NASDAQ. IPSC:NASDAQ is the stock-level entry point for investors researching Century Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Century Therapeutics, Inc. is a public company traded under the ticker IPSC in the American market. The company has a market capitalization of approximately $380.5 million. Century Therapeutics focuses on developing innovative cell therapies for cancer treatment.

IPSC:NASDAQUSDUSUpdated September 11, 2026
Century Therapeutics, Inc. logo
Ticker
IPSC:NASDAQ
Asset type
Stock
Market cap
$351.3M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Century Therapeutics, Inc. IPSC:NASDAQ stock context

This page tracks Century Therapeutics, Inc.'s IPSC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPSC:NASDAQ. IPSC:NASDAQ is the stock-level entry point for investors researching Century Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Century Therapeutics, Inc. is a public company traded under the ticker IPSC in the American market. The company has a market capitalization of approximately $380.5 million. Century Therapeutics focuses on developing innovative cell therapies for cancer treatment.

Latest news from Century Therapeutics, Inc.

All Century Therapeutics, Inc. news →

Research Century Therapeutics, Inc.

Alternate listings